![](/img/cover-not-exists.png)
P169 - Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets
B. Bokemeyer, A. Dignass, T. Stijnen, H. VeermanVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/s1873-9946(09)60196-3
File:
PDF, 42 KB
english, 2009